Europe's week: AstraZeneca jab troubles and Turkey's diplomacy mistake

The European Medicines Agency said the Oxford/AstraZeneca vaccine could potentially cause rare blood clots and Commission President von der Leyen got sidelined in Ankara.

Here's a look at two key stories making the news in Brussels this week.